Attorneys for the model allege that Cutera used Jenner's photo in advertisements for acne laser treatment without permission.» Read More
Rumors spread across Cuba that the Cuban Adjustment Act may come to an end, prompting a flood of Cubans to the United States.
Giuseppe Castagna, CEO of Banca Popolare di Milano, discusses the bank's results and the potential for a merger with other banks.
The FBI confirmed on Monday that its investigation connected to Hillary Clinton’s private email server continues. MSNBC reports.
DraftKings has received a gambling license to operate in the U.K., even as it fights that label to operate in the United States.
Eliminating high-denomination currency notes would help deter tax evasion, financial crime, terrorism and corruption, the ex-head of Standard Chartered Bank has argued.
A former top executive was arrested on Friday and accused by U.S. prosecutors of trading on inside information.
The president of Sinochem Group, China's energy and chemicals conglomerates, is under investigation for discipline violations, authorities said.
As if low prices weren't enough for the oil market, it must not hold their breath in the face of a potential new law.
Lorna Wendt wanted a 50-50 split of assets from top GE executive Gary Wendt during their 1990s divorce.
Will "Flash Boys" star IEX succeed in becoming a stock exchange with a speed bump? Tim Quast weighs in.
CNBC's Eamon Javers reports on government involvement in drug prices.
In an age of terror, its high time that global leaders get this unregulated industry under control, says Ami Daniel.
Former Turing Pharmaceuticals CEO Martin Shkreli was escorted from a drug price hike hearing after pleading the Fifth Amendment. CNBC's Meg Tirrell reports on comments by Rep. John Duncan (R-Tenn.) on Shkreli's what he calls "arrogance."
Former Turing Pharmaceuticals CEO Martin Shkreli has tweeted after being excused from a drug price hearing on Capitol Hill. He says "it is hard to accept that these imbeciles represent the people in our government."
CNBC's Meg Tirrell reports from Capitol Hill, where former Turing Pharmaceuticals CEO Martin Shkreli's invoked the Fifth Amendment at a drug price hike hearing.
Former Turing Pharmaceuticals CEO Martin Shkreli pleads the Fifth Amendment before Congress, and Shkreli's Attorney Benjamin Brafman attempts to address Congress.
Former Turing Pharmaceuticals CEO Martin Shkreli's Attorney Benjamin Brafman speaks to the press after Shkreli was excused from a House panel hearing.
Martin Shkreli's Attorney Benjamin Brafman attempted to address Congress in a hearing on drug price hikes, in which he was told to be seated. CNBC's Jim Cramer weighs in.
Former Turing Pharmaceuticals CEO Martin Shkreli is escorted out after pleading the Fifth Amendment in his testimony before the House Oversight Committee hearing on drug price hikes.
Rep. Elijah Cummings presses former Turing Pharmaceuticals CEO Martin Shkreli on Capitol Hill, as he testifies before the House Oversight Committee hearing on drug price hikes, invoking the Fifth Amendment.